Patent · US Expired

.DELTA.5-androstenes useful for promoting weight maintenance or weight loss and treatment process

US5424463A · kind A · utility

29Cited by

8References

6Claims

0Family size

Assignee

Humanetics Corporation · US

Inventors

Henry A. Lardy · Madison, US
Ieva L. Reich · Madison, US
Yong Wei · Taichung, TW

Key dates

Filing date	Oct 24, 1994
Grant date	Jun 13, 1995
Priority date	—
Expiry date	Oct 24, 2014

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J1/0022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for promoting weight control by treating a subject with a therapeutic amount of one of the .DELTA.5-androstenes listed below to stimulate weight control without affecting appetite or inducing the synthesis of sex hormones. .DELTA.5-Androstenes providing the desired biological activities include: PA1 .DELTA.5-Androstene-3.beta.,7.alpha.-diol-17-one PA1 .DELTA.5-Androstene-3.beta.-ol-7,17-dione PA1 .DELTA.5-Androstene-3.beta.,7.alpha.,17.beta.-triol PA1 .DELTA.5-Androstene-3.beta.,17.beta.-diol-7-one PA1 .DELTA.5-Androstene-3.beta.-acetoxy-7,16,17-trione PA1 .DELTA.5-Androstene-3.beta.,16.alpha.-dihydroxy-7,17-dione PA1 .DELTA.5-Androstene-3.alpha.-propionoxy-16.beta.-acetoxy-7,17-dione PA1 .DELTA.5-Androstene-3.beta.,7.alpha.,17.beta.-triol-16-one PA1 .DELTA.5-Androstene-3.beta.,17.beta.-diol-7,16-dione PA1 .DELTA.5-Androstene-3.beta.,16.alpha.,17.beta.-triol-7-one.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.